197 related articles for article (PubMed ID: 33985395)
1. An overview of ProTide technology and its implications to drug discovery.
Serpi M; Pertusati F
Expert Opin Drug Discov; 2021 Oct; 16(10):1149-1161. PubMed ID: 33985395
[No Abstract] [Full Text] [Related]
2. The ProTide Prodrug Technology: From the Concept to the Clinic.
Mehellou Y; Rattan HS; Balzarini J
J Med Chem; 2018 Mar; 61(6):2211-2226. PubMed ID: 28792763
[TBL] [Abstract][Full Text] [Related]
3. The ProTides Boom.
Mehellou Y
ChemMedChem; 2016 Jun; 11(11):1114-6. PubMed ID: 27159529
[TBL] [Abstract][Full Text] [Related]
4. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.
Slusarczyk M; Serpi M; Pertusati F
Antivir Chem Chemother; 2018; 26():2040206618775243. PubMed ID: 29792071
[TBL] [Abstract][Full Text] [Related]
5. Advancement of Prodrug Approaches for Nucleotide Antiviral Agents.
Li Y; Yang B; Quan Y; Li Z
Curr Top Med Chem; 2021; 21(32):2909-2927. PubMed ID: 34323189
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of phosphoramidate prodrugs: ProTide approach.
Serpi M; Madela K; Pertusati F; Slusarczyk M
Curr Protoc Nucleic Acid Chem; 2013 Jun; Chapter 15():15.5.1-15.5.15. PubMed ID: 23775807
[TBL] [Abstract][Full Text] [Related]
7. Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.
Sinokrot H; Smerat T; Najjar A; Karaman R
Molecules; 2017 Oct; 22(10):. PubMed ID: 29035325
[No Abstract] [Full Text] [Related]
8. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells.
Mehellou Y; Balzarini J; McGuigan C
ChemMedChem; 2009 Nov; 4(11):1779-91. PubMed ID: 19760699
[TBL] [Abstract][Full Text] [Related]
9. Could 5'-N and S ProTide analogues work as prodrugs of antiviral agents?
Procházková E; Hřebabecký H; Dejmek M; Šála M; Šmídková M; Tloušťová E; Zborníková E; Eyer L; Růžek D; Nencka R
Bioorg Med Chem Lett; 2020 Feb; 30(4):126897. PubMed ID: 31882298
[TBL] [Abstract][Full Text] [Related]
10. Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells.
Bernatchez JA; Coste M; Beck S; Wells GA; Luna LA; Clark AE; Zhu Z; Hecht D; Rich JN; Sohl CD; Purse BW; Siqueira-Neto JL
Viruses; 2019 Apr; 11(4):. PubMed ID: 31010044
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides.
McGuigan C; Bourdin C; Derudas M; Hamon N; Hinsinger K; Kandil S; Madela K; Meneghesso S; Pertusati F; Serpi M; Slusarczyk M; Chamberlain S; Kolykhalov A; Vernachio J; Vanpouille C; Introini A; Margolis L; Balzarini J
Eur J Med Chem; 2013; 70():326-40. PubMed ID: 24177359
[TBL] [Abstract][Full Text] [Related]
12. Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
Thornton PJ; Kadri H; Miccoli A; Mehellou Y
J Med Chem; 2016 Dec; 59(23):10400-10410. PubMed ID: 27559756
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-herpetic activity of phosphoramidate ProTides.
Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P
ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629
[TBL] [Abstract][Full Text] [Related]
14. Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy.
Pertusati F; Serpi M; McGuigan C
Antivir Chem Chemother; 2012 May; 22(5):181-203. PubMed ID: 22182785
[TBL] [Abstract][Full Text] [Related]
15. Phosphoramidate ProTides of the anticancer agent FUDR successfully deliver the preformed bioactive monophosphate in cells and confer advantage over the parent nucleoside.
McGuigan C; Murziani P; Slusarczyk M; Gonczy B; Vande Voorde J; Liekens S; Balzarini J
J Med Chem; 2011 Oct; 54(20):7247-58. PubMed ID: 21892829
[TBL] [Abstract][Full Text] [Related]
16. Symmetrical diamidate prodrugs of nucleotide analogues for drug delivery.
Pertusati F; McGuigan C; Serpi M
Curr Protoc Nucleic Acid Chem; 2015 Mar; 60():15.6.1-15.6.10. PubMed ID: 25754890
[TBL] [Abstract][Full Text] [Related]
17. New Heights for ProTides?
Ballatore C
J Med Chem; 2021 Nov; 64(22):16422-16424. PubMed ID: 34783565
[TBL] [Abstract][Full Text] [Related]
18. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121
[TBL] [Abstract][Full Text] [Related]
19. Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin.
Derudas M; Brancale A; Naesens L; Neyts J; Balzarini J; McGuigan C
Bioorg Med Chem; 2010 Apr; 18(7):2748-55. PubMed ID: 20207546
[TBL] [Abstract][Full Text] [Related]
20. Reactive cyclic intermediates in the ProTide prodrugs activation: trapping the elusive pentavalent phosphorane.
Procházková E; Navrátil R; Janeba Z; Roithová J; Baszczyňski O
Org Biomol Chem; 2019 Jan; 17(2):315-320. PubMed ID: 30543240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
